Hong Kong Stock Anomaly: Quanxin Biology-B (02509.HK) Rises Over 6%, Internationalization of BD is the Company's Core Strategy this Year, Salelex's Sales Expected to Reach 300 Million Yuan This Year.

According to the Securities Times app, Qianxin Biological-B (02509.HK) surged more than 6%, reaching a high of 19.88 Hong Kong dollars, the highest since October last year. The stock price has risen more than 1.6 times so far this year. As of the time of writing, it increased by 6.38%, closing at 19.68 Hong Kong dollars, with a turnover of 5.7147 million Hong Kong dollars.